Role of phospholipase D in agonist-stimulated lysophosphatidic acid synthesis by ovarian cancer cells

Journal of Lipid Research

Volumn 44, Issue 10, 2003, Pages 1963-1975

  Luquain, Céline ^a   Singh, Anurag ^a   Wang, Lixin ^b   Natarajan, Vishwanathan ^b   Morris, Andrew J ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenosine 5 triphosphate; Enzymatic assay; Lysophosphatidic acid phosphatase; Phosphatidic acid; Phospholipase A2; Phospholipase D1 phospholipase D2 isoforms; Purinergic receptor; Uridine 5 triphosphate

Indexed keywords

ISOENZYME; LYSOPHOSPHATIDIC ACID; PHOSPHATIDIC ACID; PHOSPHOLIPASE A2; PHOSPHOLIPASE D; PHOSPHOLIPASE D1; PHOSPHOLIPASE D2; PURINE P2Y RECEPTOR; PURINE P2Y4 RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; ENZYME ACTIVITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LIPID HYDROLYSIS; OVARY CANCER; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0242290818     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M300188-JLR200     Document Type: Article

References (40)

1. Hla, T., M. J. Lee, N. Ancellin, J. H. Paik, and M. J. Kluk. 2001. Lysophospholipids-receptor revelations. Science. 294: 1875-1878.
2. Tigyi, G. 2001. Physiological responses to lysophosphatidic acid and related glycero-phospholipids. Prostaglandins. 64: 47-62.
3. Gerrard, J. M., and P. Robinson. 1989. Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombin. Biochim. Biophys. Acta. 1001: 282-285.
4. Fourcade, O., M. F. Simon, C. Viode, N. Rugani, F. Leballe, A. Ragab, B. Fournie, L. Sarda, and H. Chap. 1995. Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell. 80: 919-927.
5. Eichholtz, T., K. Jalink, I. Fahrenfort, and W. H. Moolenaar. 1993. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem. J. 291: 677-680.
6. Pages, G., A. Girard, O. Jeanneton, P. Barbe, C. Wolf, M. Lafontan, P. Valer, and J. S. Saulnier-Blache. 2000. LPA as a paracrine mediator of adipocyte growth and function. Ann. N. Y. Acad. Sci. 905: 159-164.
7. Shen, Z., J. Belinson, R. E. Morton, Y. Xu, and Y. Xu. 1998. Phorbol 12-myristate 13-acetate stimulates lysophosphatidic acid secretion from ovarian and cervical cancer cells but not from breast or leukemia cells. Gynecol. Oncol. 71: 364-368.
8. Gaits, F., O. Fourcade, F. le Balle, G. Gueguen, B. Gaige, A. Gassama-Diagne, J. Fauvel, J. P. Salles, G. Mauco, M. F. Simon, and H. Chap. 1997. Lysophosphatidic acid as a phospholipid mediator: pathways of synthesis. FEBS Lett. 410: 54-58.
9. Tokumura, A., K. Harada, K. Fukuzawa, and H. Tsukatani. 1986. Involvement of lysophospholipase D in the production of lysophosphatidic acid in rat plasma. Biochim. Biophys. Acta. 875: 31-38.
10. Umezu-Goto, M., Y. Kishi, A. Taira, K. Hama, N. Dohmae, K. Takio, T. Yamori, G. B. Mills, K. Inoue, J. Aoki, and H. Arai. 2002. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J. Cell Biol. 158: 227-233.
11. Snitko, E. T. Yoon, and W. Cho. 1997. High specificity of human secretory class II phospholipase A2 for phosphatidic acid. Biochem. J. 321: 737-741.
12. Xu, Y., X. J. Fang, G. Casey, and G. B. Mills. 1995. Lysophospholipids activate ovarian and breast cancer cells. Biochem. J. 309: 933-940.
13. Pustilnik, T. B., V. Estrella, J. R. Wiener, M. Mao, A. Eder, M. A. Watt, R. C. Bast, Jr., and G. B. Mills. 1999. Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells. Clin. Cancer Res. 5: 3704-3710.
14. Mills, G. B., A. Eder, X. Fang, Y. Hasegawa, M. Mao, Y. Lu, J. Tanyi, F. H. Tabassam, J. Wiener, R. Lapushin, S. Yu, J. A. Parrott, T. Compton, W. Tribley, D. Fishman, M. S. Stack, D. Gaudette, R. Jaffe, T. Furui, J. Aoki, and J. R. Erickson. 2002. Critical role of lysophospholipids in the pathophysiology, diagnosis, and management of ovarian cancer. Cancer Treat. Res. 107: 259-283.
15. Xu, Y., D. C. Gaudette, J. D. Boynton, A. Frankel, X. J. Fang, A. Sharma, J. Hurteau, G. Casey, A. Goodbody, and A. Mellors. 1995. Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients. Clin. Cancer Res. 1: 1223-1232.
16. Eder, A. M., T. Sasagawa, M. Mao, J. Aoki, and G. B. Mills. 2000. Constitutive and lysophosphatidic acid (LPA)-induced LPA production: role of phospholipase D and phospholipase A2. Clin. Cancer Res. 6: 2482-2491.
17. Sciorra, V. A., and A. J. Morris. 1999. Sequential actions of phospholipase D and phosphatidic acid phosphohydrolase 2b generate diglyceride in mammalian cells. Mol. Biol. Cell. 10: 3863-3876.
18. Sciorra, V. A., S. A. Rudge, G. D. Prestwich, M. A. Frohman, J. Engebrecht, and A. J. Morris. 1999. Identification of a phosphoinositide binding motif that mediates activation of mammalian and yeast phospholipase D isoenzymes. EMBO J. 18: 5911-5921.
19. Sciorra, V. A., S. A. Rudge, J. Wang, S. McLaughlin, J. Engebrecht, and A. J. Morris. 2002. Dual role for phosphoinositides in regulation of yeast and mammalian phospholipase D enzymes. J. Cell Biol. 159: 1039-1049.
20. Bandoh, K., J. Aoki, H. Hosono, S. Kobayashi, T. Kobayashi, K. Murakami-Murofushi, M. Tsujimoto, H. Arai, and K. Inoue. 1999. Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid. J. Biol. Chem. 274: 27776-27785.
21. Higgs, H. N., and J. A. Glomset. 1994. Identification of a phosphatidic acid-preferring phospholipase A1 from bovine brain and testis. Proc. Natl. Acad. Sci. USA. 91: 9574-9578.
22. Hiroyama, M., and T. Takenawa. 1998. Purification and characterization of a lysophosphatidic acid-specific phosphatase. Biochem. J. 336: 483-489.
23. Hiroyama, M., and T. Takenawa. 1999. Isolation of a cDNA encoding human lysophosphatidic acid phosphatase that is involved in the regulation of mitochondrial lipid biosynthesis. J. Biol. Chem. 274: 29172-29180.
24. Boarder, M. R., G. A. Weisman, J. T. Turner, and G. F. Wilkinson. 1995. G protein-coupled P2 purinoceptors: from molecular biology to functional responses. Trends Pharmacol. Sci. 16: 133-139.
25. von Kugelgen, I., and A. Wetter. 2000. Molecular pharmacology of P2Y-receptors. Naunyn Schmiedebergs Arch. Pharmacol. 362: 310-323.
26. Lazarowski, E. R., W. C. Watt, M. J. Stutts, R. C. Boucher, and T. K. Harden. 1995. Pharmacological selectivity of the cloned human P2U-purinoceptor: potent activation by diadenosine tetraphosphate. Br. J. Pharmacol. 116: 1619-1627.
27. Schachter, J. B., Q. Li, J. L. Boyer, R. A. Nicholas, and T. K. Harden. 1996. Second messenger cascade specificity and pharmacological selectivity of the human P2Y1-purinoceptor. Br. J. Pharmacol. 118: 167-173.
28. Charlton, S. J., C. A. Brown, G. A. Weisman, J. T. Turner, L. Erb, and M. R. Boarder. 1996. Cloned and transfected P2Y4 receptors: characterization of a suramin and PPADS-insensitive response to UTP. Br. J. Pharmacol. 119: 1301-1303.
29. Kennedy, C., A. D. Qi, C. L. Herold, T. K. Harden, and R. A. Nicholas. 2000. ATP, an agonist at the rat P2Y(4) receptor, is an antagonist at the human P2Y(4) receptor. Mol. Pharmacol. 57: 926-931.
30. Frohman, M. A., and A. J. Morris. 1999. Phospholipase D structure and regulation. Chem. Phys. Lipids. 98: 127-140.
31. Rizzo, M. A., K. Shome, C. Vasudevan, D. B. Stolz, T. C. Sung, M. A. Frohman, S. C. Watkins, and G. Romero. 1999. Phospholipase D and its product, phosphatidic acid, mediate agonist-dependent raf-1 translocation to the plasma membrane and the activation of the mitogen-activated protein kinase pathway. J. Biol. Chem. 274: 1131-1139.
32. Vitale, N., A. S. Caumont, S. Chasserot-Golaz, G. Du, S. Wu, V. A. Sciorra, A. J. Morris, M. A. Frohman, and M. F. Bader. 2001. Phospholipase D1: a key factor for the exocytotic machinery in neuroendocrine cells. EMBO J. 20: 2424-2434.
33. Valet, P., C. Pages, O. Jeanneton, D. Daviaud, P. Barbe, M. Record, J. S. Saulnier-Blache, and M. Lafontan. 1998. Alpha2-adrenergic receptor-mediated release of lysophosphatidic acid by adipocytes. A paracrine signal for preadipocyte growth. J. Clin. Invest. 101: 1431-1438.
34. Saunier-Blache, J. S., A. Girard, M. F. Simon, M. Lafontan, and P. Valet. 2000. A simple and highly sensitive radioenzymatic assay for lysophosphatidic acid quantitation. J. Lipid Res. 41: 1947-1951.
35. Simon, M. F., A. Rey, I. Castan-Laurel, S. Gres, D. Sibrac, P. Valet, and J. S. Saulnier-Blache. 2002. Expression of ectolipid phosphate phosphohydrolases in 3T3F442A preadipocytes and adipocytes. Involvement in the control of lysophosphatidic acid production. J. Biol. Chem. 277: 23131-23136.
36. Schultze-Mosgau, A., A. C. Katzur, K. K. Arora, S. S. Stojilkovic, K. Diedrich, and O. Ortmann. 2000. Characterization of calcium-mobilizing, purinergic P2Y(2) receptors in human ovarian cancer cells. Mol. Hum. Reprod. 6: 435-442.
37. Popper, L. D., and S. Batra. 1993. Calcium mobilization and cell proliferation activated by extracellular ATP in human ovarian tumour cells. Cell Calcium. 14: 209-218.
38. Tang, J., R. W. Kriz, N. Wolfman, M. Shaffer, J. Sechra, and S. S. Jones. 1997. A novel cytosolic calcium-independent phospholipase A2 contains eight ankyrin motifs. J. Biol. Chem. 272: 8567-8575.
39. Sonoda, H., J. Aoki, T. Hiramatsu, M. Ishida, K. Bandoh, Y. Nagai, R. Taguchi, K. Inoue, and H. Arai. 2002. A novel phosphatidic acid-selective phospholipase Al that produces lysophosphatidic acid. J. Biol. Chem. 37: 34254-34263.
40. Tansi, J. L., A. J. Morris, and M. Wolf. 2003. Lysophosphatidic acid (LPA) is required for the growth, survival and tumorigenesis of ovarian cancer cells: validation of the LPA signaling cascade as a target for therapy in ovarian cancer. Cancer Res. 63: 1073-1082.